advanceCOR GmbH

Biotechnology

Products/services: advanceCOR is a clinical drug developing company, focusing on novel therapeutics and diagnostics for the treatment of heart and vascular diseases. The focus is on the personalized treatment of cardiovascular diseases with large unmet medical need. We provide truly innovative treatments with a companion diagnostic. advanceCOR´s activities and experiences comprise all steps from research to clinical drug development and commercialization. One project (Revacept) is in the phase II study at different university hospitals. One project is in the preclinical phase (COR-2) and others in the scientific test stage (COR-3). advanceCOR carries out GLP-certified measurements of substances in buffer and serum for preclinical and clinical drug development. advanceCOR has also received a good manufacturing practice (GMP) certificate to carry out analytical studies, and has been granted the status of a drug manufacturer. advanceCOR is a clinical drug developing company, focusing on novel therapeutics and diagnostics for the treatment of heart and vascular diseases. The focus is on the personalized treatment of cardiovascular diseases with large unmet medical need. We provide truly innovative treatments with a companion diagnostic. advanceCOR´s activities and experiences comprise all steps from research to clinical drug development and commercialization. One project (Revacept) is in the phase II study at different university hospitals. One project is in the preclinical phase (COR-2) and others in the scientific test stage (COR-3). ... read more 

    • Short facts
      • Research & Development
    • Year founded 2012
    • 25 Employees (site)
    • Turnover: not available
    Company
    advanceCOR GmbH
    Street
    Fraunhoferstr. 9a
    PC/City
    82152 Planegg
    County
    München / Upper Bavaria
    Phone
    +49 89 2000204-10
    Fax
    +49 89 2000204-20
    Email
    info@advancecor.com
    Homepage
    http://www.advancecor.de/
    Language skills
    English, German
    Contact person
    Management: Prof. Dr. Martin Ungerer (Mr.)
    Management: Prof. Dr. Götz Münch (Mr.)
    Location Map
    Key to Bavaria Map
  • Core competencies

    not available

    Key sectors / sub-sectors
    • Biotechnology: Therapeutic drug development
    NACE industries
    • Scientific research and development 72
    • Research and experimental development on natural sciences and engineering 72.1
    • Research and experimental development on biotechnology 72.11
    Certifications / awards

    not available

    Sales markets - target industries
    not available
    Sales markets - target countries
    not available
    Cooperation offers
    not available